September 25, 2023
Participants Like Mikaela Fuel Research Advances
Participating in a clinical trial for type 1 diabetes (T1D) was easy for 9-year-old Mikaela. “Everyone was really nice. I just had to drink a milkshake with some medicine in it and get an IV.
September 21, 2023
Revolutionary Microscope to Fuel Immunology Breakthroughs
What if we could take a blood sample from a person with rheumatoid arthritis, zero in on the immune cells that cause the disease, and watch what they’re doing in real-time video?
September 19, 2023
An Insider's Look Into Clinical Trials at BRI
Before medicines become widely available, they have to be rigorously tested — first in the lab, then in people through clinical trials.
June 30, 2023
Big Data Reveals Surprising Defense Against COVID-19
“If you’d asked me in March 2020, I’d have said the pandemic was going to be really bad for my asthma patients. But we saw the opposite,” says Matt Altman, MD, MPhil, who treats patients with allergies and asthma at UW Medicine and conducts research at BRI.
June 30, 2023
What Do T Cells Like to Eat? The Answer Could Stop Multiple Sclerosis
Cells, like people, get their energy from sugars, proteins and fats. Many cells have highly specialized diets — think of some loving kale while others prefer Texas BBQ.
June 30, 2023
To Belgium and Back Again to Study Beta Cells
BRI researchers are working to develop a groundbreaking new approach to treat type 1 diabetes (T1D). They aim to turn T cells that cause T1D into regulatory T cells (Tregs) that protect you from T1D.
June 30, 2023
Using Epidemiology to Fight Pancreas Cancer
It only took one statistic to get Meg Mandelson, PhD, interested in studying pancreas cancer. “Five-year survival rates have greatly improved for almost every cancer over the past two decades,” she says. “Pancreas cancer is one of the few that hasn’t.”
March 29, 2023
Learning How Tregs Keep Your Immune System in Check
The immune system keeps us healthy by maintaining a delicate balance. Every cell has a purpose: Some sound the alarm when they see an invader. Some attack germs that don’t belong. And some patrol the other cells in the immune system to make sure they’re doing their job.
March 14, 2023
Prediction and Prevention: A New Paradigm in Autoimmune Disease
The FDA recently approved teplizumab, a groundbreaking therapy that signals a paradigm shift in treating not only T1D but all autoimmune diseases.
March 14, 2023
Computer Science Reveals Possible Drug Target for Deadly Childhood Leukemia
Dr. Bolouri is an expert in using computer science to advance biomedical research. Working with Soheil Meshinchi, MD, PhD, and his team at Fred Hutch Cancer Center, they made a recent discovery that may lead to new treatments for certain forms of pediatric acute myeloid leukemia (AML).
